https://scholars.lib.ntu.edu.tw/handle/123456789/533442
標題: | Comedication with interacting drugs predisposes amiodarone users in cardiac and surgical intensive care units to acute liver injury: A retrospective analysis | 作者: | YUNN-FANG HO Chou H.-Y. Chu J.-S. PING-ING LEE |
公開日期: | 2018 | 卷: | 97 | 期: | 37 | 起(迄)頁: | e12301 | 來源出版物: | Medicine (United States) | 摘要: | Risk factors and underlying mechanisms for liver injury associated with amiodarone remain elusive. This study aimed to investigate the drug-related covariates for acute liver injury by amiodarone—an intriguing compound of high lipophilicity, with a long half-life and notable efficacy. The medical, pharmacy, and laboratory records of new amiodarone users admitted to the cardiac or surgical intensive care units of a medical center were examined retrospectively. A Cox regression model with time-varying dose-related variables of amiodarone was utilized to estimate the hazard ratio (HR) of amiodarone-associated liver injury while adjusting for concomitant therapy and relevant covariates. Of the 131 eligible patients among 6,572 amiodarone users (46,402 prescriptions), 6 were identified as amiodarone-associated liver injury cases. In comparison to controls (n = 125), this liver injury cohort (n = 6) had significantly higher numbers of amiodarone-interacting (2.7 ± 2.0 vs 0.9 ± 0.9 drugs, P = .02) and hepatotoxic (3.8 ± 0.8 vs 2.5 ± 1.7 drugs, P = .03) comedications. The number of comedications with amiodarone-interacting potential (HR 2.07, 95% confidence interval [CI] 1.024.22, P = .04) and amiodarone cumulative doses standardized by body surface area (HR 6.82, 95% CI 1.72–27.04, P = .01) were independent risk factors for liver injury associated with amiodarone. Drug-related (amiodarone cumulative dose, interacting drugs) factors were significant predictors of amiodarone-associated acute liver injury. A prudent evaluation of each medication profile is warranted to attain precision medicine at the level of patient care, especially for those treated by medications with complex physicochemical and pharmacokinetic properties, such as amiodarone. Copyright ? 2018 the Author(s). Published by Wolters Kluwer Health, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053719485&doi=10.1097%2fMD.0000000000012301&partnerID=40&md5=da41d78a488ace2798783f659d563c46 https://scholars.lib.ntu.edu.tw/handle/123456789/533442 |
ISSN: | 257974 | DOI: | 10.1097/MD.0000000000012301 | SDG/關鍵字: | alanine aminotransferase; amiodarone; ampicillin; carvedilol; fentanyl; paracetamol; amiodarone; antiarrhythmic agent; adult; aged; Article; controlled study; coronary care unit; disease predisposition; drug induced disease; female; human; incidence; length of stay; liver injury; liver toxicity; major clinical study; male; polypharmacy; prescription; retrospective study; surgical intensive care unit; adolescent; drug interaction; evaluation study; intensive care unit; middle aged; polypharmacy; proportional hazards model; regression analysis; risk factor; toxic hepatitis; young adult; Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Drug Interactions; Female; Humans; Intensive Care Units; Male; Middle Aged; Polypharmacy; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors; Young Adult |
顯示於: | 臨床藥學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。